Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 11, Number 6—June 2005

Research

Methicillin-resistant Staphylococcus aureus and Vancomycin-resistant Enterococci in Rural Communities, Western United States

Kurt B. Stevenson*†Comments to Author , Katy Searle†, Gregory Stoddard†, and Matthew H. Samore†‡
Author affiliations: *Qualis Health, Boise, Idaho, USA; †University of Utah School of Medicine, Salt Lake City, Utah, USA; ‡VA Salt Lake City Health Care System, Salt Lake City, Utah, USA

Main Article

Table 2

Clinical sources for MRSA cultures*

Clinical source No. (%)
HA-MRSA, N = 405 CA-MRSA with CFs, N = 79 CA-MRSA without CFs, N = 240 p value†
Skin and soft tissue 197 (49) 47 (60) 156 (65) <0.0001
Urine 61 (15) 11 (14) 32 (13) NS
Blood 33 (8) 2 (3) 3 (1) <0.0001
Sputum 89 (22) 12 (15) 15 (6) <0.0001
Other 23 (6) 7 (9) 34 (14) 0.001
Unknown 2 (1) 0 (0) 0 (0) NS

*MRSA, methicillin-resistant Staphylococcus aureus; HA, heathcare-associated; CA, community-associated; CFs, coexisting factors; NS, not significant.
†Based on Fisher exact test.

Main Article

Top of Page

USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO